Form 4: Elevance Health Executive's Routine Stock Transactions

Elevance Health EVP Peter D. Haytaian reported the vesting of restricted stock units and subsequent tax-related share dispositions.

Summary

• Peter D. Haytaian, EVP & Pres Carelon & CarelonRx at Elevance Health, Inc. (ELV), reported changes in his beneficial ownership of common stock.
• On March 2, 2026, 2,865 performance-based restricted share units (RSUs) vested, resulting in an acquisition of common stock at a price of $0.
• Also on March 2, 2026, 1,201 shares of common stock were disposed of at $294.07 per share to satisfy tax liabilities incident to the vesting of previously granted restricted stock.
• On March 3, 2026, an additional 446 shares of common stock were disposed of at $284.03 per share for tax liabilities related to restricted stock vesting.
• Following these reported transactions, Haytaian beneficially owns 27,222 shares of Elevance Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, reflecting routine executive compensation activities involving RSU vesting and tax-related share dispositions, with no significant positive or negative implications for the company's outlook.

Positives

• The vesting of 2,865 performance-based restricted share units indicates the achievement of specific performance targets by the executive.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transaction filings like Form 4 provide transparency into executive stock ownership changes. These specific transactions are routine for RSU vesting and tax payments, offering no direct insight into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Provides transparency into executive stock ownership, but these routine transactions are unlikely to significantly impact shareholder value or company strategy.

Key Dates

Recommendation

The filing details routine executive stock transactions related to the vesting of restricted stock units and subsequent tax withholdings. These are standard compensation events and do not provide new information that would warrant a change in investment recommendation.

Keywords

Elevance Health, ELV, insider transaction, Form 4, restricted stock units, RSU vesting, executive compensation, stock disposition